Cargando…
The Development of a Parenteral Pharmaceutical Formulation of a New Class of Compounds of Nitrosourea
Despite the rapid development of medical technologies, chemotherapy treatment still occupies an important place in clinical oncology. In this regard, the current research in this area focuses on the synthesis of new highly effective antitumor substances that have minimal side effects and the develop...
Autores principales: | Nikolaeva, Ludmila, Oborotova, Natalia, Bunyatyan, Natalia, Zhang, Xi, Sanarova, Ekaterina, Lantsova, Anna, Orlova, Olga, Polozkova, Alevtina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198043/ https://www.ncbi.nlm.nih.gov/pubmed/27809286 http://dx.doi.org/10.3390/ph9040068 |
Ejemplares similares
-
A new indolocarbazole derivative in melanoma and carcinoma lung in vivo treatment
por: Lantsova, Anna, et al.
Publicado: (2021) -
Formulation and Evaluation of Pharmaceutically Equivalent Parenteral Depot Suspension of Methyl Prednisolone Acetate
por: Alam, A., et al.
Publicado: (2009) -
Parenteral Formulation of Zopiclone
por: Swamy, P. V., et al.
Publicado: (2008) -
Identification and Quantification by NMR Spectroscopy of the 22R and 22S Epimers in Budesonide Pharmaceutical Forms
por: Kuz’mina, Natalia E., et al.
Publicado: (2022) -
Pharmaceutical Point of View on Parenteral Nutrition
por: Stawny, M., et al.
Publicado: (2013)